417 related articles for article (PubMed ID: 17387695)
1. Predicting human drug pharmacokinetics from in vitro permeability using an absorption-disposition model.
Fliszar KA; Hill BT; Foster N
J Pharm Sci; 2007 Aug; 96(8):2161-70. PubMed ID: 17387695
[TBL] [Abstract][Full Text] [Related]
2. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).
Usansky HH; Sinko PJ
J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900
[TBL] [Abstract][Full Text] [Related]
3. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
4. Predicting the oral absorption of a poorly soluble, poorly permeable weak base using biorelevant dissolution and transfer model tests coupled with a physiologically based pharmacokinetic model.
Wagner C; Jantratid E; Kesisoglou F; Vertzoni M; Reppas C; B Dressman J
Eur J Pharm Biopharm; 2012 Sep; 82(1):127-38. PubMed ID: 22652546
[TBL] [Abstract][Full Text] [Related]
5. Prospective Predictions of Human Pharmacokinetics for Eighteen Compounds.
Zhang T; Heimbach T; Lin W; Zhang J; He H
J Pharm Sci; 2015 Sep; 104(9):2795-806. PubMed ID: 25690565
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates.
Kortejärvi H; Urtti A; Yliperttula M
Eur J Pharm Sci; 2007 Feb; 30(2):155-66. PubMed ID: 17187967
[TBL] [Abstract][Full Text] [Related]
7. Prediction of human pharmacokinetics--gastrointestinal absorption.
Fagerholm U
J Pharm Pharmacol; 2007 Jul; 59(7):905-16. PubMed ID: 17637184
[TBL] [Abstract][Full Text] [Related]
8. A new physiologically based pharmacokinetic model for the prediction of gastrointestinal drug absorption: translocation model.
Ando H; Hisaka A; Suzuki H
Drug Metab Dispos; 2015 Apr; 43(4):590-602. PubMed ID: 25616403
[TBL] [Abstract][Full Text] [Related]
9. PBPK models for the prediction of in vivo performance of oral dosage forms.
Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
[TBL] [Abstract][Full Text] [Related]
10. Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test.
Takano R; Sugano K; Higashida A; Hayashi Y; Machida M; Aso Y; Yamashita S
Pharm Res; 2006 Jun; 23(6):1144-56. PubMed ID: 16715363
[TBL] [Abstract][Full Text] [Related]
11. In silico drug absorption tract: An agent-based biomimetic model for human oral drug absorption.
Deng J; Jhandey A; Zhu X; Yang Z; Yik KFP; Zuo Z; Lam TN
PLoS One; 2018; 13(8):e0203361. PubMed ID: 30169515
[TBL] [Abstract][Full Text] [Related]
12. In Silico Modeling of Gastrointestinal Drug Absorption: Predictive Performance of Three Physiologically Based Absorption Models.
Sjögren E; Thörn H; Tannergren C
Mol Pharm; 2016 Jun; 13(6):1763-78. PubMed ID: 26926043
[TBL] [Abstract][Full Text] [Related]
13. Exploring the role of different drug transport routes in permeability screening.
Matsson P; Bergström CA; Nagahara N; Tavelin S; Norinder U; Artursson P
J Med Chem; 2005 Jan; 48(2):604-13. PubMed ID: 15658873
[TBL] [Abstract][Full Text] [Related]
14. Advantage of the Dissolution/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage.
Miyaji Y; Fujii Y; Takeyama S; Kawai Y; Kataoka M; Takahashi M; Yamashita S
Mol Pharm; 2016 May; 13(5):1564-74. PubMed ID: 27031624
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a novel in vitro Caco-2 hepatocyte hybrid system for predicting in vivo oral bioavailability.
Lau YY; Chen YH; Liu TT; Li C; Cui X; White RE; Cheng KC
Drug Metab Dispos; 2004 Sep; 32(9):937-42. PubMed ID: 15319334
[TBL] [Abstract][Full Text] [Related]
16. Prediction of the human oral bioavailability by using in vitro and in silico drug related parameters in a physiologically based absorption model.
Paixão P; Gouveia LF; Morais JA
Int J Pharm; 2012 Jun; 429(1-2):84-98. PubMed ID: 22449410
[TBL] [Abstract][Full Text] [Related]
17. Modelling of drug disposition kinetics in in vitro intestinal absorption cell models.
Heikkinen AT; Korjamo T; Mönkkönen J
Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):180-8. PubMed ID: 20030630
[TBL] [Abstract][Full Text] [Related]
18. In silico prediction of human oral absorption based on QSAR analyses of PAMPA permeability.
Akamatsu M; Fujikawa M; Nakao K; Shimizu R
Chem Biodivers; 2009 Nov; 6(11):1845-66. PubMed ID: 19937826
[TBL] [Abstract][Full Text] [Related]
19. A new in vitro system for evaluation of passive intestinal drug absorption: establishment of a double artificial membrane permeation assay.
Kataoka M; Tsuneishi S; Maeda Y; Masaoka Y; Sakuma S; Yamashita S
Eur J Pharm Biopharm; 2014 Nov; 88(3):840-6. PubMed ID: 25304077
[TBL] [Abstract][Full Text] [Related]
20. Effect of P-glycoprotein expression levels on the concentration-dependent permeability of drugs to the cell membrane.
Shirasaka Y; Sakane T; Yamashita S
J Pharm Sci; 2008 Jan; 97(1):553-65. PubMed ID: 17828734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
